MicroRNA Expression and Function in Cardiac Ischemic Injury

Ambros, V. (2004). The functions of animal microRNAs. Nature, 431(7006), 350–355. Bartel, D. P. (2004). MicroRNAs: Genomics, biogenesis, mechanism, function. Cell, 116(2), 281–297. Carleton, M., Cleary, M. A., & Linsley, P. S. (2007). MicroRNAs and cell cycle regulation. Cell Cycle, 6(17), 2127–2132. Harfe, B. D. (2005). MicroRNAs in vertebrate development. Current Opinion in Genetics and Development, 15(4), 410–415. Lau, N. C., Lim, L. P., Weinstein, E. G., & Bartel, D. P. (2001). An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science, 294(5543), 858–862. Boehm, M., & Slack, F. J. (2006). MicroRNA control of lifespan and metabolism. Cell Cycle, 5(8), 837–840. Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., Macdonald, P. E., et al. (2004). A pancreatic islet-specific microRNA regulates insulin secretion. Nature, 432(7014), 226–230. Landthaler, M., Yalcin, A., & Tuschl, T. (2004). The human DiGeorge syndrome critical region gene 8 and its D. melanogaster homolog are required for miRNA biogenesis. Current Biology, 14(23), 2162–2167. Jin, P., Alisch, R. S., & Warren, S. T. (2004). RNA and microRNAs in fragile X mental retardation. Nature Cell Biology, 6(11), 1048–1053. Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., et al. (2005). MicroRNA expression profiles classify human cancers. Nature, 435(7043), 834–838. Volinia, S., Calin, G. A., Liu, C. G., Ambs, S., Cimmino, A., Petrocca, F., et al. (2006). A microRNA expression signature in human solid tumors defines cancer targets. Proceedings of the National Academy of Science of the United State of America, 103(7), 2257–2261. Latronico, M. V., & Condorelli, G. (2009). MicroRNAs and cardiac pathology. Nature Reviews Cardiology, 6(6), 419–429. Barringhaus, K. G., & Zamore, P. D. (2009). MicroRNAs: Regulating a change of heart. Circulation, 119(16), 2217–2224. Thum, T., Catalucci, D., & Bauersachs, J. (2008). MicroRNAs: Novel regulators in cardiac development and disease. Cardiovascular Research, 79(4), 562–570. Dong, S., Cheng, Y., Yang, J., Li, J., Liu, X., Wang, X., et al. (2009). MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. Journal of Biological Chemistry, 284(43), 29514–29525. van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., et al. (2008). Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proceedings of the National Academy of Science of the United State of America, 105(35), 13027–13032. Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., & Tuschl, T. (2002). Identification of tissue-specific miRNAs from mouse. Current Biology, 12, 735–739. Ji, X., Takahashi, R., Hiura, Y., Hirokawa, G., Fukushima, Y., & Iwai, N. (2009). Plasma miR-208 as a biomarker of myocardial injury. Clinical Chemistry, 55, 1944–1949. Ji, R., Cheng, Y., Yue, J., Yang, J., Liu, X., Chen, H., et al. (2007). MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circulation Research, 100, 1579–1588. Chen, J. F., Murchison, E. P., Tang, R., Callis, T. E., Tatsuguchi, M., Deng, Z., et al. (2008). Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proceedings of the National Academy of Science of the United State of America, 105, 2111–2216. Yang, B., Lin, H., Xiao, J., Luo, X., Li, B., Lu, Y., et al. (2007). The muscle-specific microRNA miR-1 causes cardiac arrhythmias by targeting GJA1 and KCNJ2 genes. Nature Medicine, 13, 486–491. Xu, C., Lu, Y., Pan, Z., Chu, W., Luo, X., Lin, H., et al. (2007). The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. Journal of Cell Science, 120(Pt 17), 3045–3052. Tang, Y., Zheng, J., Sun, Y., Wu, Z., Liu, Z., & Huang, G. (2009). MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. International Heart Journal, 50(3), 377–387. Yin, C., Salloum, F. N., & Kukreja, R. C. (2009). A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70. Circulation Research, 104(5), 572–575. Ren, X. P., Wu, J., Wang, X., Sartor, M. A., Qian, J., Jones, K., et al. (2009). MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation, 119(17), 2357–2366. Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., et al. (2007). Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell, 129(2), 303–317. Nerheim, P., Krishnan, S. C., Olshansky, B., & Shivkumar, K. (2001). Apoptosis in the genesis of cardiac rhythm disorders. Cardiology Clinics, 19, 155–163. James, T. N. (1994). Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias. Circulation, 90, 556–573. Wu, F., Yang, Z., & Li, G. (2009). Role of specific microRNAs for endothelial function and angiogenesis. Biochemical and Biophysical Research Communications, 386(4), 549–553. Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., et al. (2009). MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science, 324(5935), 1710–1713.